Berberine sensitizes rapamycin‑mediated human hepatoma cell death in vitro

Guo,Na; Yan,Aili; Gao,Xingchun; Chen,Yanke; He,Xinying; Hu,Zhifang; Mi,Man; Tang,Xu; Gou,Xingchun

doi:10.3892/mmr.2014.2608

December-2014 Volume 10 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

December-2014 Volume 10 Issue 6

Full Size Image

Article

Berberine sensitizes rapamycin‑mediated human hepatoma cell death in vitro

Authors:
- Na Guo
- Aili Yan
- Xingchun Gao
- Yanke Chen
- Xinying He
- Zhifang Hu
- Man Mi
- Xu Tang
- Xingchun Gou
View Affiliations / Copyright

Affiliations: Laboratory of Cell Biology and Translational Medicine, Institute of Basic Medical Science, X'ian Medical University, Xi'an, Shaanxi 710021, P.R. China, Department of Cell Biology and Genetics, College of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi 710032, P.R. China, Department of Pathology, Sichuan College of Traditional Chinese Medicine, Mianyang, Sichuan 721000, P.R. China
Pages: 3132-3138
|
Published online on: October 8, 2014

https://doi.org/10.3892/mmr.2014.2608
Expand metrics +

Abstract

Rapamycin is clinically used as an immunosuppressant. Increasing evidence suggests that rapamycin has an important inhibitory role in the development and progression of different types of cancer and that it is a promising candidate for cancer chemotherapy. Berberine is an isoquinoline alkaloid isolated from medicinal plant species, which has been used in traditional Chinese medicine with no significant side effects. Recent research has demonstrated that berberine has anticancer activity against various types of cancer, mediated through the suppression of mammalian target of rapamycin (mTOR). The present study aimed to investigate the in vitro synergistic anticancer effect of combined treatment of rapamycin at various concentrations (0, 10, 50, 100 and 200 nM) and berberine (62.5 µM) in SMMC7721 and HepG2 hepatocellular carcinoma (HCC) cell lines, and the potential underlying molecular mechanism. The combined use of rapamycin and berberine was found to have a synergistic cytotoxic effect, with berberine observed to maintain the cyotoxic effect of rapamycin on HCC cells at a lower rapamycin concentration. Moreover, the cells treated with the combination of the two agents exhibited significantly decreased protein levels of phosphorylated (p)‑p70S6 kinase 1 (Thr389), the downstream effector of mTOR, compared with the cells treated with rapamycin or berberine alone. Furthermore, overexpression of cluster of differentiation (CD) 147, a transmembrance glycoprotein associated with the anticancer effects of berberine, was found to upregulate p‑mTOR expression and inhibit cell death in SMMC7721 cells co‑treated with rapamycin and berberine. In conclusion, the findings of the present study suggest that the combined use of rapamycin and berberine may improve HCC therapy through synergistically inhibiting the mTOR signaling pathway, which is at least in part, mediated through CD147.

View Figures

View References

1	Saunders RN, Metcalfe MS and Nicholson ML: Rapamycin in transplantation: a review of the evidence. Kidney Int. 59:3–16. 2001. View Article : Google Scholar : PubMed/NCBI
2	Gibbons JJ, Abraham RT and Yu K: Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth. Semin Oncol. 36(Suppl 3): S3–S17. 2009. View Article : Google Scholar : PubMed/NCBI
3	Zhou L, Huang Y, Li J and Wang Z: The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma. Med Oncol. 27:255–261. 2010. View Article : Google Scholar : PubMed/NCBI
4	Owonikoko TK and Khuri FR: Targeting the PI3K/AKT/mTOR pathway: biomarkers of success and tribulation. Am Soc Clin Oncol Educ Book. 2013:395–401. 2013. View Article : Google Scholar : PubMed/NCBI
5	Finn RS, Poon RT, Yau T, et al: Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma. J Hepatol. 59:1271–1277. 2013. View Article : Google Scholar : PubMed/NCBI
6	Fasolo A and Sessa C: Targeting mTOR pathways in human malignancies. Curr Pharm Des. 18:2766–2777. 2012. View Article : Google Scholar : PubMed/NCBI
7	Zhou Q, Lui VW and Yeo W: Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Future Oncol. 7:1149–1167. 2011. View Article : Google Scholar : PubMed/NCBI
8	Kudo M: mTOR inhibitor for the treatment of hepatocellular carcinoma. Dig Dis. 29:310–315. 2011. View Article : Google Scholar : PubMed/NCBI
9	Sun Y, Xun K, Wang Y and Chen X: A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs. 20:757–769. 2009. View Article : Google Scholar : PubMed/NCBI
10	Tang J, Feng Y, Tsao S, Wang N, et al: Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol. 126:5–17. 2009. View Article : Google Scholar : PubMed/NCBI
11	Wang N, Feng Y, Zhu M, et al: Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem. 111:1426–1436. 2010. View Article : Google Scholar : PubMed/NCBI
12	Hou Q, Tang X, Liu H, et al: Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147. Cancer Sci. 102:1287–1292. 2011. View Article : Google Scholar : PubMed/NCBI
13	Tang X, Guo N, Xu L, et al: CD147/EMMPRIN: an effective therapeutic target for hepatocellular carcinoma. J Drug Target. Aug 29–2012.(Epub ahead of print).
14	Espert L, Denizot M, Grimaldi M, et al: Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest. 116:2161–2172. 2006. View Article : Google Scholar : PubMed/NCBI
15	Valentim L, Laurence KM, Townsend PA, et al: Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury. J Mol Cell Cardiol. 40:846–852. 2006. View Article : Google Scholar : PubMed/NCBI
16	Gou X, Ru Q, Zhang H, et al: HAb18G/CD147 inhibits starvation-induced autophagy in human hepatoma cell SMMC7721 with an involvement of Beclin 1 down-regulation. Cancer Sci. 100:837–843. 2009. View Article : Google Scholar : PubMed/NCBI
17	Kim DW, Ahan SH and Kim TY: Enhancement of arsenic trioxide (As(2)O(3))-mediated apoptosis using berberine in human neuroblastoma SH-SY5Y cells. J Korean Neurosurg Soc. 42:392–399. 2007. View Article : Google Scholar
18	Letasiová S, Jantová S, Cipák L and Múcková M: Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. Cancer Lett. 239:254–262. 2006.PubMed/NCBI
19	Grabinski N, Ewald F, Hofmann BT, et al: Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells. Mol Cancer. 11:852012. View Article : Google Scholar : PubMed/NCBI
20	Wu C, Miao X, Huang L, et al: Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet. 44:62–66. 2011. View Article : Google Scholar : PubMed/NCBI